BrightGene

BrightGene Bio-Medical Technology Co., Ltd. is a biopharmaceutical company researching, developing, manufacturing, and distributing pharmaceutical products. It specializes in high-barrier intermediates, active pharmaceutical ingredients (APIs), and finished drugs, encompassing innovative therapies and high-end generics. Its pipeline targets anti-tumor, anti-infection, cardiovascular, and metabolic diseases, leveraging advanced technologies.

Founded in 2001, BrightGene originated from the recognized demand for advanced pharmaceutical solutions and quality APIs. Its foundation was built on a commitment to scientific research and continuous innovation in biopharmaceuticals. While founder details remain private, BrightGene's trajectory reflects persistent dedication to scientific rigor and strategic development.

BrightGene supplies essential components and finished drugs to the global pharmaceutical market. Its mission centers on continuous innovation and health protection, aiming to develop effective, accessible treatments. The company's vision is to advance biopharmaceutical science, improving human well-being and offering solutions for complex diseases.